Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C).

Karski JM, Dowd NP, Joiner R, Carroll J, Peniston C, Bailey K, Glynn MF, Teasdale SJ, Cheng DC.

J Cardiothorac Vasc Anesth. 1998 Dec;12(6):642-6.

PMID:
9854660
2.

Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation.

Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg H, Roger SL, Glynn MF.

Anesthesiology. 1996 Nov;85(5):1043-8; discussion 30A-31A.

PMID:
8916821
3.

Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial.

Karski JM, Teasdale SJ, Norman P, Carroll J, VanKessel K, Wong P, Glynn MF.

J Thorac Cardiovasc Surg. 1995 Sep;110(3):835-42.

4.

Spontaneous spinal epidural hematoma in a patient with a mechanical aortic valve taking warfarin.

Maingi M, Glynn MF, Scully HE, Graham AF, Floras JS.

Can J Cardiol. 1995 May;11(5):429-32.

PMID:
7750040
5.
6.

Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid.

Karski JM, Teasdale SJ, Norman PH, Carroll JA, Weisel RD, Glynn MF.

J Cardiothorac Vasc Anesth. 1993 Aug;7(4):431-5.

PMID:
8104526
7.

Differential stimulation of macrophage procoagulant activity by vascular grafts.

Kalman PG, Rotstein OD, Niven J, Glynn MF, Romaschin AD.

J Vasc Surg. 1993 Mar;17(3):531-7.

PMID:
8445749
8.

Microsurgical free flap transfer in sickle cell disease.

Richards RS, Bowen CV, Glynn MF.

Ann Plast Surg. 1992 Sep;29(3):278-81.

PMID:
1524382
9.

The effect of warm heart surgery on postoperative bleeding.

Yau TM, Carson S, Weisel RD, Ivanov J, Sun Z, Yu R, Glynn MF, Teasdale SJ.

J Thorac Cardiovasc Surg. 1992 Jun;103(6):1155-62; discussion 1162-3.

PMID:
1597980
10.

Effect of systemic fibrinogen depletion on intraabdominal abscess formation.

McRitchie DI, Girotti MJ, Glynn MF, Goldberg JM, Rotstein OD.

J Lab Clin Med. 1991 Jul;118(1):48-55.

PMID:
2066642
11.

Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin.

Trimble MS, Glynn MF, Brain MC.

Am J Hematol. 1991 Jun;37(2):126-7.

PMID:
2069157
12.

A reevaluation of heparin requirements for cardiopulmonary bypass.

Cardoso PF, Yamazaki F, Keshavjee S, Schaefers HJ, Hsieh CM, Wang LS, Glynn MF, Patterson GA, Cooper JD.

J Thorac Cardiovasc Surg. 1991 Jan;101(1):153-60.

PMID:
1986159
14.

Ancrod improves survival in murine systemic lupus erythematosus.

Cole EH, Glynn MF, Laskin CA, Sweet J, Mason N, Levy GA.

Kidney Int. 1990 Jan;37(1):29-35.

15.

Dipyridamole for coronary artery bypass surgery.

Teoh KH, Weisel RD, Ivanov J, Teasdale SJ, Glynn MF.

Thromb Res Suppl. 1990;12:91-9.

PMID:
2082492
16.

Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass.

Zulys VJ, Teasdale SJ, Michel ER, Skala RA, Keating SE, Viger JR, Glynn MF.

Anesthesiology. 1989 Dec;71(6):870-7.

PMID:
2589675
17.

Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.

Teasdale SJ, Zulys VJ, Mycyk T, Baird RJ, Glynn MF.

Ann Thorac Surg. 1989 Nov;48(5):712-3.

PMID:
2818066
18.

Treatment of primary liver graft nonfunction with prostaglandin E1.

Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, Blendis LM, Superina RA, Glynn MF, Langer B, et al.

Transplantation. 1989 Sep;48(3):447-53.

PMID:
2675405
19.

Low-dose fibrinolytic therapy for recent lower extremity thromboembolism.

Sniderman KW, Kalman PG, Odurny A, Shewchun J, Glynn MF.

Can Assoc Radiol J. 1989 Apr;40(2):98-103.

PMID:
2702509
20.

Prostaglandin E1 for primary nonfunction following liver transplantation.

Greig PD, Woolf GM, Abecassis M, Forster J, Strasberg SM, Taylor BR, Superina RA, Glynn MF, Ettles M, Blendis LM, et al.

Transplant Proc. 1989 Apr;21(2):3360-1. No abstract available.

PMID:
2652837
21.

Predictors of graft function following liver transplantation.

Forster J, Greig PD, Glynn MF, Poon A, Levy GA, Superina RA, Langer B.

Transplant Proc. 1989 Apr;21(2):3356-7. No abstract available.

PMID:
2652835
22.

Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival.

Greig PD, Woolf GM, Abecassis M, Strasberg SM, Taylor B, Superina RA, Langer B, Glynn MF, Ettles M, Blendis L, et al.

Transplant Proc. 1989 Feb;21(1 Pt 2):2385-8. No abstract available.

PMID:
2652777
23.

Coagulation factors as indicators of early graft function following liver transplantation.

Forster J, Greig PD, Glynn MF, Poon A, Levy G, Superina RA, Langer B.

Transplant Proc. 1989 Feb;21(1 Pt 2):2308-10. No abstract available.

PMID:
2496499
24.

Ten-year experience with extracorporeal membrane oxygenation for severe respiratory failure.

Egan TM, Duffin J, Glynn MF, Todd TR, DeMajo W, Murphy E, Fox L, Cooper JD.

Chest. 1988 Oct;94(4):681-7.

PMID:
3168565
25.

Preservation of platelets and blood products by intravenously administered dipyridamole in patients who undergo coronary artery bypass grafting.

Reilly PA, Thompson M, Bayer A, Kazim F, Rosenfeld J, Glynn MF.

Can J Surg. 1987 Jul;30(4):260-4.

PMID:
3496948
26.

Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia.

Teoh KH, Christakis GT, Weisel RD, Madonik MM, Ivanov J, Warbick-Cerone A, Johnston LG, Cawthorn RH, Mullen JC, Glynn MF, et al.

J Surg Res. 1987 Jun;42(6):642-52.

PMID:
3586631
28.

AIDS in a patient with hemophilia receiving mainly cryoprecipitate.

Gerstein HC, Fanning MM, Read SE, Shepherd FA, Glynn MF.

Can Med Assoc J. 1984 Jul 1;131(1):45-7.

29.

Limitations of blood conservation.

Weisel RD, Charlesworth DC, Mickleborough LL, Fremes SE, Ivanov J, Mickle DA, Teasdale SJ, Glynn MF, Scully HE, Goldman BS, et al.

J Thorac Cardiovasc Surg. 1984 Jul;88(1):26-38.

PMID:
6376959
30.

The blood bank: no overdrafts from here!

Glynn MF.

Can Anaesth Soc J. 1984 May;31(3 Pt 2):S28-30. No abstract available.

PMID:
6372958
31.

Haemostatic abnormalities in systemic lupus erythematosus.

Gladman DD, Urowitz MB, Tozman EC, Glynn MF.

Q J Med. 1983 Summer;52(207):424-33.

PMID:
6647751
32.

Thrombosis in the upper extremity: use of Doppler ultrasound for diagnosis.

Bernier V, Scott AA, Glynn MF.

Can Anaesth Soc J. 1981 Nov;28(6):579-84.

PMID:
7306863
33.

Tests for hemostasis and their relevance to venous thrombosis.

Johnston DW, Scott AA, Glynn MF.

Can J Surg. 1980 Jul;23(4):373-80.

PMID:
6968239
34.

Therapy for thrombotic occlusion of long-term intravenous alimentation catheters.

Glynn MF, Langer B, Jeejeebhoy KN.

JPEN J Parenter Enteral Nutr. 1980 Jul-Aug;4(4):387-90.

PMID:
6774122
35.

Amelioration of cardiac hemolytic anemia by sulfinpyrazone therapy.

Owen J, Seidenfeld AM, Glynn MF.

Can Med Assoc J. 1980 Mar 8;122(5):554-6. No abstract available.

36.

A technique for preclotting vascular grafts.

Glynn MF, Williams WG.

Ann Thorac Surg. 1980 Feb;29(2):182-3.

PMID:
7356371
37.

Complications after peritoneovenous shunting for ascites.

Greig PD, Langer B, Blendis LM, Taylor BR, Glynn MF.

Am J Surg. 1980 Jan;139(1):125-31.

PMID:
7350836
38.

Aorta-coronary bypass in a patient with sickle cell trait.

Heiner M, Teasdale SJ, David T, Scott AA, Glynn MF.

Can Anaesth Soc J. 1979 Sep;26(5):428-34.

PMID:
314837
39.

Pure red cell aplasia with an inhibitor to erythropoiesis.

Seidenfeld AM, Owen J, Prchal JF, Glynn MF.

Can Med Assoc J. 1979 Jul 21;121(2):188-90. No abstract available.

40.

Thrombosis and free fatty acids in patients subjected to total hip arthroplasty.

Armstrong P, Scott AA, Angel A, Glynn MF.

Can J Surg. 1979 Jul;22(4):366-8.

PMID:
455167
41.

Heparin monitoring and thrombosis.

Glynn MF.

Am J Clin Pathol. 1979 Apr;71(4):397-400.

PMID:
443197
42.

Post-transfusion purpura cured by steroid therapy in a man.

Seidenfeld AM, Owen J, Glynn MF.

Can Med Assoc J. 1978 May 20;118(10):1285-6. No abstract available.

43.

Effect of a new antithrombotic agent at microvenous anastomotic sites.

Griffiths MV, Fredrickson JM, Glynn MF.

Arch Otolaryngol. 1977 Jun;103(6):318-21.

PMID:
869762
44.

An in vitro measurement of bleeding time.

Blakely J, Prchal JT, Glynn MF, Bitmanis J, Girouard-Antonopoulos E, Bailey M.

J Lab Clin Med. 1977 Jun;89(6):1306-13.

PMID:
405442
45.

Cardiorespiratory failure secondary to peripheral pulmonary emboli. Survival following a combination of prolonged extracorporeal membrane oxygenator support and pulmonary embolectomy.

Cooper JD, Teasdale S, Nelems JM, Glynn MF, MacGregor DC, Duffin J, Scott AA.

J Thorac Cardiovasc Surg. 1976 Jun;71(6):872-7.

PMID:
1271837
46.

Grafting of the major veins: the value of anti-thrombotic drugs to maintain patency.

Thomas JM, Glynn MF, Rickwood AM, Gough MH.

Br J Surg. 1976 Mar;63(3):189-95.

PMID:
1260246
47.

Combination of membrane oxygenator support and pulmonary lavage for acute respiratory failure.

Cooper JD, Duffin J, Glynn MF, Nelems JM, Teasdale S, Scott AA, Martin B.

J Thorac Cardiovasc Surg. 1976 Feb;71(2):304-8.

PMID:
1060893
48.

The effect of sulfinpyrazone on platelet and pulmonary responses to onset of membrane oxygenator perfusion.

Birek A, Duffin J, Glynn MF, Cooper JD.

Trans Am Soc Artif Intern Organs. 1976;22:94-101. No abstract available.

PMID:
951897
50.

The role of the platelet membrane in platelet function. II. 5-Hydroxytryptamine (serotonin) uptake.

Glynn MF.

Am J Clin Pathol. 1973 Nov;60(5):636-43. No abstract available.

PMID:
4356448

Supplemental Content

Loading ...
Support Center